92693-02-2 Usage
Origin
A metabolic product of arachidonic acid.
Enzyme involvement
Derived from the action of the enzyme 15-lipoxygenase.
Category
Bioactive lipid mediator.
Involvement in processes
Inflammation, immune response, and vascular regulation.
Properties
Anti-inflammatory and vasodilatory.
Role
Regulation of blood pressure and kidney function.
Implication in diseases
Hypertension, atherosclerosis, and cancer.
Current status
Ongoing research for biological functions and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 92693-02-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,6,9 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 92693-02:
(7*9)+(6*2)+(5*6)+(4*9)+(3*3)+(2*0)+(1*2)=152
152 % 10 = 2
So 92693-02-2 is a valid CAS Registry Number.
92693-02-2Relevant academic research and scientific papers
PHARMACEUTICALLY ACCEPTABLE SALTS OF POLYUNSATURATED HYDROXY FATTY ACIDS
-
Paragraph 00144-00147, (2015/06/03)
The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same.
Asymmetric synthesis of unnatural (Z,Z,E)-octadecatrienoid and eicosatrienoid by lipoxygenase-catalyzed oxygenation
Nanda,Yadav
, p. 1799 - 1806 (2007/10/03)
The asymmetric synthesis of unnatural 13-hydroxy-(6Z,9Z,11E,13S)-octadecatrienoid and 15-hydroxy-(8Z,11Z,13E,15S)-eicosatrienoid is described using a biomimetic oxidation route. The main highlights of this synthesis are the asymmetric hydroxylation of the substrate with soybean lipoxygenase and cis selective Wittig olefination.
